How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
It's Super Bowl Sunday, and whether you are a Patriots or a Seahawks fan, the rules of physics equally apply. And one of the most beautiful things to watch in the sport is the spiral pass, where the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results